- conflicts or gaps
- [[{"field": {"value": "funding.total_equity_raised", "source_urls": ["https://www.cbinsights.com/company/verge-genomics/financials", "https://endpoints.news/verge-genomics-als-drug-fails-as-biotech-shifts-to-partner-model/"]}, "issue": {"value": "CB Insights reports $176.12M total across 8 rounds including undisclosed Series C (Oct 2024); primary sources document only Seed $4M + Series A $32M + Series B $98M (~$134M); Endpoints confirms no financing announced since Dec 2021 Series B", "source_urls": ["https://www.cbinsights.com/company/verge-genomics/financials", "https://endpoints.news/verge-genomics-als-drug-fails-as-biotech-shifts-to-partner-model/", "https://vcnewsdaily.com/Verge%20Genomics/venture-funding.php"]}}, {"field": {"value": "employees.current_count", "source_urls": ["https://www.ycombinator.com/companies/verge-genomics", "https://www.linkedin.com/company/verge-genomics", "https://tracxn.com/d/companies/vergegenomics/__rjypa3XQPYcCzCZRSDUuzi4SB0qY1rslwly4w2Kv1ys"]}, "issue": {"value": "Headcount ranges from 23 (LinkedIn) to 26 (Tracxn Mar 2026) to 50 (YC, stale) to 54 (AeroLeads, likely stale); ~90% layoff reported but post-layoff exact count not officially disclosed", "source_urls": ["https://www.biopharmadive.com/news/verge-genomics-labs-neuroscience-AI-drug-discovery/821229/", "https://www.linkedin.com/company/verge-genomics", "https://tracxn.com/d/companies/vergegenomics/__rjypa3XQPYcCzCZRSDUuzi4SB0qY1rslwly4w2Kv1ys", "https://www.ycombinator.com/companies/verge-genomics"]}}, {"field": {"value": "identity.brand_name", "source_urls": ["https://www.ycombinator.com/companies/verge-genomics", "https://www.vergegenomics.com"]}, "issue": {"value": "Company operates as Verge Labs since May 2026 but YC directory, LinkedIn slug, and vergegenomics.com domain still use Verge Genomics branding", "source_urls": ["https://www.prnewswire.com/news-releases/verge-labs-launches-as-a-frontier-ai-lab-for-human-disease-biology-302782601.html", "https://www.ycombinator.com/companies/verge-genomics", "https://www.vergegenomics.com"]}}, {"field": {"value": "founders.jason_chen", "source_urls": ["https://www.ycombinator.com/companies/verge-genomics", "https://foundertrace.com/companies/verge_genomics/"]}, "issue": {"value": "YC lists only Alice Zhang as founder; TechCrunch 2015 and FounderTrace list Jason Chen and Grace Li as co-founders; current roles at Verge unverified in primary company sources", "source_urls": ["https://www.ycombinator.com/companies/verge-genomics", "https://techcrunch.com/2015/07/21/verge-genomics-wants-to-cure-neurodegenerative-diseases-through-advanced-algorithms/", "https://foundertrace.com/companies/verge_genomics/"]}}, {"field": {"value": "partnerships.ferrer_vrg50635", "source_urls": ["https://www.fiercebiotech.com/biotech/verge-genomics-drops-sole-clinical-candidate-return-ai-drug-discovery-roots"]}, "issue": {"value": "Ferrer co-development deal for VRG50635 (Mar 2024, up to €112.5M) status unknown after program termination; neither party publicly confirmed termination or continuation", "source_urls": ["https://www.fiercebiotech.com/biotech/verge-genomics-drops-sole-clinical-candidate-return-ai-drug-discovery-roots", "https://endpoints.news/verge-genomics-als-drug-fails-as-biotech-shifts-to-partner-model/"]}}, {"field": {"value": "products.vrg201_clinical_status", "source_urls": ["https://endpoints.news/verge-genomics-als-drug-fails-as-biotech-shifts-to-partner-model/", "https://www.globenewswire.com/news-release/2024/12/16/2997376/0/en/Verge-Genomics-Announces-New-Development-Candidate-VRG201-a-Novel-Maintenance-Therapy-for-Long-Term-Weight-Management.html"]}, "issue": {"value": "VRG201 nominated as second development candidate Dec 2024 but no IND/clinical-trial filing found; Endpoints reported it had not entered clinic by Dec 2025; fate after platform pivot unclear", "source_urls": ["https://endpoints.news/verge-genomics-als-drug-fails-as-biotech-shifts-to-partner-model/", "https://www.globenewswire.com/news-release/2024/12/16/2997376/0/en/Verge-Genomics-Announces-New-Development-Candidate-VRG201-a-Novel-Maintenance-Therapy-for-Long-Term-Weight-Management.html"]}}, {"field": {"value": "funding.lilly_deal_value", "source_urls": ["https://www.vergegenomics.com/news-blog/verge-genomics-secures-98-million-in-new-financing", "https://www.vergegenomics.com/news-blog/verge-genomics-announces-milestones-in-collaboration-with-lilly-to-discover-and-develop-novel-treatments-for-als"]}, "issue": {"value": "Lilly collaboration total deal value cited as $706M (Series B press release) vs $694M (Nov 2024 milestone release); likely reflects milestone accounting differences not reconciled publicly", "source_urls": ["https://www.vergegenomics.com/news-blog/verge-genomics-secures-98-million-in-new-financing", "https://www.vergegenomics.com/news-blog/verge-genomics-announces-milestones-in-collaboration-with-lilly-to-discover-and-develop-novel-treatments-for-als"]}}, {"field": {"value": "leadership.c_suite_turnover", "source_urls": ["https://endpoints.news/verge-genomics-als-drug-fails-as-biotech-shifts-to-partner-model/"]}, "issue": {"value": "Endpoints reports most C-suite departed in prior 20 months (CFO, CSO, CMO, President/CBO Jane Rhodes); no complete current executive roster published as of Dec 2025", "source_urls": ["https://endpoints.news/verge-genomics-als-drug-fails-as-biotech-shifts-to-partner-model/", "https://www.prnewswire.com/news-releases/verge-labs-launches-as-a-frontier-ai-lab-for-human-disease-biology-302782601.html"]}}, {"field": {"value": "valuation", "source_urls": ["https://vcnewsdaily.com/Verge%20Genomics/venture-funding.php"]}, "issue": {"value": "No public post-money valuation disclosed for any equity round", "source_urls": ["https://vcnewsdaily.com/Verge%20Genomics/venture-funding.php", "https://www.vergegenomics.com/news-blog/verge-genomics-secures-98-million-in-new-financing"]}}]]
- source urls
- ["https://endpoints.news/verge-genomics-als-drug-fails-as-biotech-shifts-to-partner-model/", "https://foundertrace.com/companies/verge_genomics/", "https://techcrunch.com/2015/07/21/verge-genomics-wants-to-cure-neurodegenerative-diseases-through-advanced-algorithms/", "https://techcrunch.com/2015/11/03/verge-genomics-on-a-quest-to-solve-neurodegenerative-disorders-picks-up-4m-seed/", "https://tracxn.com/d/companies/vergegenomics/__rjypa3XQPYcCzCZRSDUuzi4SB0qY1rslwly4w2Kv1ys", "https://vcnewsdaily.com/Verge%20Genomics/venture-funding.php", "https://www.biopharmadive.com/news/verge-genomics-labs-neuroscience-AI-drug-discovery/821229/", "https://www.cbinsights.com/company/verge-genomics/financials", "https://www.fiercebiotech.com/biotech/verge-genomics-drops-sole-clinical-candidate-return-ai-drug-discovery-roots", "https://www.forbes.com/companies/verge-genomics/", "https://www.globenewswire.com/news-release/2023/09/08/2739994/0/en/Verge-Genomics-Announces-Artificial-Intelligence-Enabled-Drug-Discovery-Collaboration-with-Alexion-for-Rare-Neurodegenerative-and-Neuromuscular-Diseases.html", "https://www.globenewswire.com/news-release/2024/12/16/2997376/0/en/Verge-Genomics-Announces-New-Development-Candidate-VRG201-a-Novel-Maintenance-Therapy-for-Long-Term-Weight-Management.html", "https://www.linkedin.com/company/verge-genomics", "https://www.prnewswire.com/news-releases/verge-labs-launches-as-a-frontier-ai-lab-for-human-disease-biology-302782601.html", "https://www.vergegenomics.com", "https://www.vergegenomics.com/news-blog/verge-genomics-announces-milestones-in-collaboration-with-lilly-to-discover-and-develop-novel-treatments-for-als", "https://www.vergegenomics.com/news-blog/verge-genomics-initiates-first-in-human-dosing-in-phase-1-trial-of-novel-therapeutic-for-als", "https://www.vergegenomics.com/news-blog/verge-genomics-secures-98-million-in-new-financing", "https://www.vergegenomics.com/pipeline", "https://www.vergelabs.blog/p/what-we-learned-from-the-trial-of", "https://www.vergelabs.blog/p/why-were-becoming-verge-labs", "https://www.ycombinator.com/blog/verge-genomics-yc-s15-uses-algorithms-find-drugs-for-brain-diseases-1000x-faster", "https://www.ycombinator.com/companies/verge-genomics"]